Dry eye showdown: SYSTANE PRO takes on MIEBO in new trial
NCT ID NCT07243275
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two eye drops—SYSTANE PRO and MIEBO—to see if SYSTANE PRO works as well as MIEBO for treating dry eye disease. About 260 adults with moderate dry eye will use one of the two drops for one month. The main goal is to measure changes in dry eye symptoms using a standard questionnaire.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SYSTANE PRO (hyaluronate, nano-sized lipids, HP-Guar) and MIEBO (perfluorohexyloctane)
What this could lead to
If SYSTANE PRO works as well as MIEBO, it could offer a more affordable or accessible option for managing dry eye symptoms.
What could go wrong
This is a Phase 4 trial comparing two existing treatments, so no major breakthrough is expected. The study is relatively small and may not show a clear difference between the two drops.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Eye Research Foundation
RECRUITINGNewport Beach, California, 92663, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Indiana Universtiy School of Optometry
RECRUITINGBloomington, Indiana, 47408, United States
-
Kannarr Eye Care
RECRUITINGPittsburg, Kansas, 66762, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Southern College of Optometry
RECRUITINGMemphis, Tennessee, 38104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••